Cysteine protease inhibitors

Details for Australian Patent Application No. 2008267166 (hide)

Owner Medivir AB

Inventors Oden, Lourdes; Grabowska, Urszula; Nilsson, Magnus; Kahnberg, Pia

Agent Davies Collison Cave

Pub. Number AU-B-2008267166

PCT Pub. Number WO2009/000877

Priority 60/929,437 27.06.07 US; 07123771.3 20.12.07 EP

Filing date 26 June 2008

Wipo publication date 31 December 2008

Acceptance publication date 21 April 2011

International Classifications

C07D 491/048 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2009/000877 Priority application(s): WO2009/000877

21 April 2011 Application Accepted

  Published as AU-B-2008267166

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008267167-Kallikrein 7 modulators

2008267158-Distributor power line communication system